Lack of evidence of increased risk of bacterial transmission during cystic fibrosis educational programmes  Winnie Ridderberg, Camilla Andersen, Michael.

Slides:



Advertisements
Similar presentations
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis  Giuseppe Valenza, Dennis Tappe, Doris.
Advertisements

Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Bacterial contamination in the environment of hospitalised children with cystic fibrosis  Agnès Ferroni, Aurélie Werkhauser-Bertrand, Muriel Le Bourgeois,
The prevalence of “risky behaviour” in adults with cystic fibrosis
Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to- patient contact  C.R. Hansen, T. Pressler, W. Ridderberg, H.K.
Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment  Winnie Ridderberg, Karen E.M.
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients  Helle Krogh Johansen, Samuel.
Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort  Margaret Rosenfeld, Julia Emerson, Sharon McNamara,
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A.
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands  R.W. Brimicombe, L. Dijkshoorn, T.J.K.
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.
Cirrhosis and other liver disease in cystic fibrosis
The risk of gastrointestinal malignancies in cystic fibrosis
Controlled clinical trials in cystic fibrosis — are we doing better?
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Molecular detection of an atypical, highly resistant, clonal Pseudomonas aeruginosa isolate in cystic fibrosis patients  Deirdre Keating, Mary J. Crowe,
Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial  S.K. Kabra, R. Pawaiya, Rakesh Lodha,
Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn 
Amyloidosis in cystic fibrosis: A case series
A.H. Gifford  Journal of Cystic Fibrosis 
Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden  Per Kristian Knudsen, Hanne.
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis  Sanja Stanojevic, Valerie Waters, Joseph L.
Inhalation solutions — Which ones may be mixed
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis  M. Wang, W. Ridderberg, C.R. Hansen, N. Høiby,
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients  E.B. Wilms, D.J. Touw, H.G.M. Heijerman 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa  Karen O. McKay, Peter J. Cooper, Peter P. van.
Higher risk of hospitalization among females with cystic fibrosis
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies  Don B. Sanders, Huichuan J. Lai,
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis  Giuseppe Valenza, Dennis Tappe, Doris.
Michael W. Konstan, David J. Pasta, Jeffrey S. Wagener, Donald R
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D
Marcus P. Kennedy, Raymond D. Coakley, Scott H. Donaldson, Robert M
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening  Fiona Cunningham, Sharon Lewis, Lisette.
Presentation transcript:

Lack of evidence of increased risk of bacterial transmission during cystic fibrosis educational programmes  Winnie Ridderberg, Camilla Andersen, Michael Væth, Vibeke Bregnballe, Niels Nørskov-Lauritsen, Peter Oluf Schiøtz  Journal of Cystic Fibrosis  Volume 15, Issue 1, Pages 109-115 (January 2016) DOI: 10.1016/j.jcf.2015.04.007 Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

Supplementary fig. 1 Dendrogram of P. aeruginosa PFGE band patterns. Journal of Cystic Fibrosis 2016 15, 109-115DOI: (10.1016/j.jcf.2015.04.007) Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

Supplementary fig. 2 Macrorestriction profiles (Spel) of P. aeroginosa isolates. Journal of Cystic Fibrosis 2016 15, 109-115DOI: (10.1016/j.jcf.2015.04.007) Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions